Cargando…

COVID-19 in patients with HIV

Detalles Bibliográficos
Autores principales:	Jones, Rachael, Nelson, Mark, Bracchi, Margherita, Asboe, David, Boffito, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255114/ https://www.ncbi.nlm.nih.gov/pubmed/32416771 http://dx.doi.org/10.1016/S2352-3018(20)30139-9

Ejemplares similares

Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART
por: Vera, Jaime H., et al.
Publicado: (2019)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

More evidence for worse COVID-19 outcomes in people with HIV
por: Boffito, Marta, et al.
Publicado: (2021)

Rapid reconfiguration of sexual health services in response to UK autochthonous transmission of mpox (monkeypox)
por: Heskin, Joseph, et al.
Publicado: (2023)

Recent advances in HIV-associated Kaposi sarcoma
por: Dalla Pria, Alessia, et al.
Publicado: (2019)

Development, Validation, and Field-Testing of an Instrument for Clinical Assessment of HIV-Associated Neuropathy and Neuropathic Pain in Resource-Restricted and Large Population Study Settings
por: Woldeamanuel, Yohannes W., et al.
Publicado: (2016)

Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis
por: Girometti, Nicolò, et al.
Publicado: (2022)

Nannizziopsis Immune Reconstitution Inflammatory Syndrome in a Patient with HIV: First Reported Case
por: Zhao, Yi, et al.
Publicado: (2021)

Long-acting antiviral agents for HIV treatment
por: Margolis, David A., et al.
Publicado: (2015)

Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
por: Cevik, Muge, et al.
Publicado: (2012)

Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor
por: Barber, Tristan, et al.
Publicado: (2014)

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors
por: Barber, Tristan J, et al.
Publicado: (2014)

Prevalence, severity, and risk factors of disability among adults living with HIV accessing routine outpatient HIV care in London, United Kingdom (UK): A cross-sectional self-report study
por: Brown, Darren A., et al.
Publicado: (2022)

The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy
por: Dalla Pria, Alessia, et al.
Publicado: (2015)

Changes in functional connectivity in people with HIV switching antiretroviral therapy
por: Toniolo, Sofia, et al.
Publicado: (2020)

Ritonavir and COVID-19: pragmatic guidance is important
por: Waters, Laura, et al.
Publicado: (2022)

Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approach
por: Dickinson, Laura, et al.
Publicado: (2014)

How to Face COVID-19 Outbreak: Reconfiguration of a Private Radiological Clinic
por: Cellina, Michaela, et al.
Publicado: (2020)

Prevention of atherosclerosis in patients living with HIV
por: De Lorenzo, Ferruccio, et al.
Publicado: (2009)

The evidence for using tenofovir disoproxil fumarate plus lamivudine as a nucleoside analogue backbone for the treatment of HIV
por: Waters, Laura, et al.
Publicado: (2021)

Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
por: Dickinson, Laura, et al.
Publicado: (2009)

PS status report no. 246 period 19.4.1976 - 16.5.1976 (weeks 17-18-19-20)
por: Asboe-Hansen, P
Publicado: (1976)

Development of long-acting ARV’s
por: Boffito, Marta
Publicado: (2014)

MPS status report no. 237: Period 5.5.1975-31.5.1975 (Weeks 19,20,21,22)
por: Asboe-Hansen, P
Publicado: (1975)

PS status report No. 245: Period 22.3.1976 - 15.4.1976 (Weeks 17-18-19-20)
por: Asboe-Hansen, P
Publicado: (1976)

Evaluation of the psychometric properties of the HIV Disability Questionnaire among adults living with HIV in the United Kingdom: A cross-sectional self-report measurement study
por: Brown, Darren A., et al.
Publicado: (2019)

PS status report No. 247: Period 17.5.1976 - 19.6.1976 (Weeks 21,22,23,24,25)
por: Asboe-Hansen, P
Publicado: (1976)

PS status report No. 249: Period 19.7.1976 - 22.8.1976 (Weeks 30,31,32,33,34)
por: Asboe-Hansen, P
Publicado: (1976)

Transmission of monkeypox virus through sexual contact – A novel route of infection
por: Heskin, Joseph, et al.
Publicado: (2022)

Non-Immunogenicity of Overlapping Gag Peptides Pulsed on Autologous Cells after Vaccination of HIV Infected Individuals
por: Kløverpris, Henrik N., et al.
Publicado: (2013)

Effect of a Modified Saquinavir/Ritonavir Dosing Regimen with Lower Dose Lead-In Phase on QTc Interval, Pharmacokinetics, Antiviral Activity and Safety in Treatment-Naïve HIV-1-Infected Patients
por: Boffito, Marta, et al.
Publicado: (2015)

COVID-19 confessions: a qualitative exploration of healthcare workers experiences of working with COVID-19
por: Bennett, Paul, et al.
Publicado: (2020)

Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
por: Dickinson, L, et al.
Publicado: (2010)

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
por: Marzolini, Catia, et al.
Publicado: (2022)

Impact of COVID-19 on the Care of Patients with HIV Infection
por: Rosas Cancio-Suárez, Marta, et al.
Publicado: (2023)

Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection
por: Boffito, Marta, et al.
Publicado: (2020)

A Phase 2 Randomized Trial Evaluating the Antiviral Activity and Safety of the Direct-Acting Antiviral Bemnifosbuvir in Ambulatory Patients with Mild or Moderate COVID-19 (MOONSONG Study)
por: Boffito, Marta, et al.
Publicado: (2023)

Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development
por: Boffito, Marta, et al.
Publicado: (2020)

A mode analyser for observation of longitudinal coupled bunch oscillations
por: Asboe-Hansen, P
Publicado: (1976)

Mps status report no. 224: Period 15.2.1974 to 9.3.1974 (Weeks 7-10)
por: Asboe-Hansen, P
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_270irdkn5m880kijg6h1vu4nsk